entertainment -WSS

entertainment

author：entertainment 2025-08-12 08:26:08 - browse：153

Adam's take main illustration — Molly Ferguson/STAT

Novartis said Monday that it intends to buy MorphoSys for just under $3 billion. The deal will not close. Six months from now, or sooner, Novartis will walk away — slightly embarrassed but otherwise unscathed — happy to pay a small breakup fee to MorphoSys to avoid owning a drug for myelofibrosis that regulators turned away.

MorphoSys will not fare as well from the breakup. Its future, and that of the drug called pelabresib at the center of the deal, will be thrown into limbo.

This is all speculation on my part, but it’s supported by separate conversations with two people familiar with pelabresib and the debate inside Novartis over the MorphoSys acquisition. They requested anonymity to discuss confidential matters.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Canadians with cystic fibrosis outlive Americans by a decade

explore

WSS

Multiple sclerosis has subtypes with different best treatments: study

Florida Supreme Court upholds state's abortion ban

Bird flu in dairy cattle: New measures to control spread to humans

STAT wants to know your pick for a great summer read or listen

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Wikipedia

entertainment

focus

The high cost of giving birth even with insurance

Hundreds died while taking an arthritis drug, but nobody alerted patients

Virginia high school admissions case could be legal follow

UnitedHealth, in a surprise, takes aim at Steward’s physician group

The high cost of giving birth even with insurance

Dexcom's push to bring CGM to type 2 diabetes patients

Sports medicine is finally prioritizing gender equality

Scientists uncover potential path to treating deadly childhood tumor

Wildfire smoke exposes gaps in outdoor worker protections

Medicare Advantage 2025 payments will dip, Biden administration says

leisure time

Drug cartel violence flares in western Mexico after vigilante leader's killing

Undocumented workers face uncertainty as immigration law takes effect in Florida

Beware reading your test results before your doctor does

First Opinion on colorectal cancer screening: letter and response

STAT wants to know your pick for a great summer read or listen

Drug cartel violence flares in western Mexico after vigilante leader's killing

explore

Wikipedia

Wikipedia

knowledge